FcRA76 protein, Streptococcus sp. group A: Clinical Trials

1 trial of FcRA76 protein, Streptococcus sp. group A, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow FcRA76 protein, Streptococcus sp. group A: new trials by email Literature Review of FcRA76 protein, Streptococcus sp. group A trials Research Report on FcRA76 protein, Streptococcus sp. group A

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Resveratrol-enriched Grape Extract (Stilvid) in Primary and Secondary Prevention of Cardiovascular Disease
Placebo in primary cardiovascular prevention (PP), Placebo in secondary prevention, Grape extract in primary prevention (PP) - Cardiovascular Diseases
Phase 2CompletedNational Research Council, Spain1502009-04-012011-11-16

Conditions studied

Cardiovascular Diseases (1)

Sponsors

National Research Council, Spain (1)

Countries

Spain (1)